Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
about
Medical versus surgical interventions for open angle glaucomaA review of the efficacy of mitomycin C in glaucoma filtration surgeryAchieving Target Pressures with Combined Surgery: Primary Patchless Ahmed Valve Combined with Phacoemulsification vs Primary Phacotrabeculectomy.Visual field improvement in the collaborative initial glaucoma treatment study.Predicting Clinical Binary Outcome Using Multivariate Longitudinal Data: Application to Patients with Newly Diagnosed Primary Open-Angle Glaucoma.Canaloplasty using iTrack 250 Microcatheter with Suture Tensioning on Schlemm's Canal.Using CorvisST tonometry to assess glaucoma progression.Factors associated with topographic changes of the optic nerve head induced by acute intraocular pressure reduction in glaucoma patientsBimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial.A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials.Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using 4 criteria for functional progression.A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy.Human scleral structural stiffness increases more rapidly with age in donors of African descent compared to donors of European descent.Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-upPrevalence and associated factors of glaucoma in rural central India. The Central India Eye and Medical Study.The impact of change in visual field on health-related quality of life the los angeles latino eye study.Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trialUsing filtered forecasting techniques to determine personalized monitoring schedules for patients with open-angle glaucoma.Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case seriesEffect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.A bayesian approach to surrogacy assessment using principal stratification in clinical trials.Relationship among visual field, blood flow, and neural structure measurements in glaucomaThe development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.Eyes with Suspicious Appearance of the Optic Disc and Normal Intraocular Pressure: Using Clinical and Epidemiological Characteristics to Differentiate Those with and without Glaucoma.Glaucoma and Driving: On-Road Driving Characteristics.The Relationship between Corvis ST Tonometry and Ocular Response Analyzer Measurements in Eyes with GlaucomaOutcomes of Late-Onset Bleb-Related Endophthalmitis Treated with Pars Plana Vitrectomy.The impact of surgical intraocular pressure reduction on visual function using various criteria to define visual field progression.Preliminary results of CO2 laser-assisted sclerectomy surgery (CLASS) in the treatment of advanced glaucoma in a Chinese populationClinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study.A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population.Can early postoperative intraocular pressure predict success following mitomycin-C augmented trabeculectomy in primary angle-closure glaucomaRisk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS)Glaucoma severity and medication adherence in a county hospital population.Intraocular pressure and glaucoma: Is physical exercise beneficial or a risk?African Descent and Glaucoma Evaluation Study (ADAGES): Racial Differences in Optic Disc Hemorrhage and Beta-Zone Parapapillary Atrophy.Olfactory Ensheathing Cells Rescue Optic Nerve Fibers in a Rat Glaucoma Model.
P2860
Q24200540-B6B6ADA9-BDCC-4AD6-98FE-E5210859D8A6Q26777325-19B286A8-BBB5-4D31-8923-BA16FCE7B35BQ27687087-5E8E32D1-115D-474F-9A45-D5EDE0930CB2Q30590721-573F811B-27DC-4F46-9258-2BE1A7C81137Q31048408-BC7F5758-5B7E-4048-9AD0-F5C75CCDDEE5Q33619418-A412EF98-644F-4C7D-A69F-ECE3E1E95B3DQ33637599-14EA8D3F-3DC4-4333-86AD-F56F9A57FA7AQ33762084-FDBF0274-7CB6-41B6-B464-DA1A86FC50C0Q33834484-EE13D125-FFF5-4C1C-8498-147E0322EDA7Q33917331-6DB45821-64D0-4F95-817E-B169BAFEDA2FQ33926694-996C15E8-3583-4291-8CF0-D4BF02D9F3ABQ33931074-7EE5ADFC-82D6-4127-B817-1C9C6E92ED2CQ34496031-5911679F-E458-474C-8B70-C5DB8F7364DBQ34517043-EE61BA26-4873-4CCA-BEE4-8F296491A5EEQ35010319-47372D3C-F554-443D-A65B-549FEEBC6444Q35085714-060E80FC-41EA-4D37-B40B-CC2BD4BEF4AEQ35179454-8E8AC55C-D70D-4C9C-BDFD-EF8ECF426651Q35247623-20E2EAB2-FADC-4A14-89EF-43CDD64D1D85Q35820480-079BC816-BC5A-42D3-961F-29F04686057DQ35831076-FAA23C5D-1DC3-455D-9AE5-93346AF90542Q35868673-B19F13AF-C488-4DA8-9E60-0D64EC0B4366Q35929958-72AFFB27-51E2-4E69-9D9F-FC47316C4037Q36002474-45B8D47E-8BF6-42F1-A753-A033C6210320Q36041958-0A4BCB9D-BFCD-4FF8-8103-486C68302755Q36074252-8E477445-A1F4-467C-A870-30BDB919AC33Q36081507-815F9D81-B5CC-4D15-BE8D-FBFF9DED0DDEQ36089524-D2D35064-3D85-4968-BCEA-83CF20A257E0Q36118600-A678BF57-9A20-4C2B-8F58-A6F1460C9CB7Q36162697-D588CDDA-9883-4DC7-B3AF-FBA52A29881DQ36177048-CF607648-9FB2-49FD-A6E6-50DAA473C959Q36187191-BDF5D11C-120D-42E2-A18C-1D03465DF3C6Q36344867-3D4B2468-2B1C-49D3-936B-19608FD4228AQ36390585-65996A9D-F338-4EA9-BC88-60F0A635A7F8Q36626225-C199EA66-698B-4B40-84B1-20B1F4E73C28Q36685477-45126143-6C1C-43CC-8EA3-C926B55FDDD5Q36718154-1FD12CD8-E6AF-425F-BC37-2B9D381C8ED3Q36906472-5ACB5F1C-DA8C-4096-A54C-EDE7C8E84B84Q37014625-2AC425B8-51AD-438E-B746-402EA81F0DA9Q37038560-939D7582-ADF2-4C92-86FB-9E67A1FB58DAQ37149359-88505036-C641-4D36-9ACF-99AD47301E1B
P2860
Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Visual field progression in th ...... nt and other baseline factors.
@ast
Visual field progression in th ...... nt and other baseline factors.
@en
type
label
Visual field progression in th ...... nt and other baseline factors.
@ast
Visual field progression in th ...... nt and other baseline factors.
@en
prefLabel
Visual field progression in th ...... nt and other baseline factors.
@ast
Visual field progression in th ...... nt and other baseline factors.
@en
P2093
P2860
P1433
P1476
Visual field progression in th ...... nt and other baseline factors.
@en
P2093
Brenda W Gillespie
CIGTS Study Investigators
David C Musch
Leslie M Niziol
Nancy K Janz
Paul R Lichter
P2860
P304
P356
10.1016/J.OPHTHA.2008.08.051
P577
2008-11-18T00:00:00Z